204 related articles for article (PubMed ID: 34505878)
1. Primary mesenchymal stromal cells in co-culture with leukaemic HL-60 cells are sensitised to cytarabine-induced genotoxicity, while leukaemic cells are protected.
Gynn LE; Anderson E; Robinson G; Wexler SA; Upstill-Goddard G; Cox C; May JE
Mutagenesis; 2021 Nov; 36(6):419-428. PubMed ID: 34505878
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced genotoxic damage to bone marrow cells: long-term implications.
May JE; Donaldson C; Gynn L; Morse HR
Mutagenesis; 2018 Sep; 33(3):241-251. PubMed ID: 30239865
[TBL] [Abstract][Full Text] [Related]
3. [Human umbilical cord mesenchymal stem cells reduce the sensitivity of HL-60 cells to cytarabine].
Cui JJ; Chi Y; Du WJ; Yang SG; Li X; Chen F; Ma FX; Lu SH; Han ZC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):760-4. PubMed ID: 23815936
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
5. The effect of bone marrow mesenchymal stromal cell exosomes on acute myeloid leukemia's biological functions: a focus on the potential role of LncRNAs.
Jalilivand S; Izadirad M; Vazifeh Shiran N; Gharehbaghian A; Naserian S
Clin Exp Med; 2024 May; 24(1):108. PubMed ID: 38777995
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow stromal dysfunction in mice administered cytosine arabinoside.
Ben-Ishay Z; Barak V
Eur J Haematol; 2001 Apr; 66(4):230-7. PubMed ID: 11380602
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia.
Rodríguez-Pardo VM; Aristizabal JA; Jaimes D; Quijano SM; de los Reyes I; Herrera MV; Solano J; Vernot JP
Hematol Oncol Stem Cell Ther; 2013; 6(3-4):89-100. PubMed ID: 24161606
[TBL] [Abstract][Full Text] [Related]
8. Review of clinical and haematological response to low-dose cytosine arabinoside in acute myeloid leukaemia.
Shtalrid M; Lotem J; Sachs L; Berrebi A
Eur J Haematol; 1987 Jan; 38(1):3-11. PubMed ID: 3472902
[TBL] [Abstract][Full Text] [Related]
9. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759
[TBL] [Abstract][Full Text] [Related]
10. Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine.
Nishi R; Shigemi H; Negoro E; Okura M; Hosono N; Yamauchi T
BMC Cancer; 2020 Oct; 20(1):984. PubMed ID: 33046037
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells.
Ahmed HMM; Nimmagadda SC; Al-Matary YS; Fiori M; May T; Frank D; Patnana PK; Récher C; Schliemann C; Mikesch JH; Koenig T; Rosenbauer F; Hartmann W; Tuckermann J; Dührsen U; Lanying W; Dugas M; Opalka B; Lenz G; Khandanpour C
Br J Haematol; 2022 Feb; 196(4):995-1006. PubMed ID: 34792186
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
[TBL] [Abstract][Full Text] [Related]
13. Aurora B inhibitor barasertib and cytarabine exert a greater-than-additive cytotoxicity in acute myeloid leukemia cells.
Yamauchi T; Uzui K; Shigemi H; Negoro E; Yoshida A; Ueda T
Cancer Sci; 2013 Jul; 104(7):926-33. PubMed ID: 23557198
[TBL] [Abstract][Full Text] [Related]
14. [In vitro effects of Wnt3a gene modification on mitigating damage of mouse bone marrow mesenchymal stem cells induced by Ara-C].
Lu G; Li ZY; Mou WW; He XP; Pan XY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1033-7. PubMed ID: 21867639
[TBL] [Abstract][Full Text] [Related]
15. [Effects of bone marrow stromal cells on the chemotherapeutic sensitivity of acute lymphoblastic leukemia cells].
Wang Y; Han ZX; Zhang JC
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):885-890. PubMed ID: 29262503
[No Abstract] [Full Text] [Related]
16. CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML.
Anderson E; Mehta P; Heywood J; Rees B; Bone H; Robinson G; Reynolds D; Salisbury V; Mayer L
Leuk Res; 2018 Nov; 74():121-129. PubMed ID: 30119908
[TBL] [Abstract][Full Text] [Related]
17. RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.
Abraham A; Varatharajan S; Karathedath S; Philip C; Lakshmi KM; Jayavelu AK; Mohanan E; Janet NB; Srivastava VM; Shaji RV; Zhang W; Abraham A; Viswabandya A; George B; Chandy M; Srivastava A; Mathews V; Balasubramanian P
Pharmacogenomics; 2015 Jul; 16(8):877-90. PubMed ID: 26083014
[TBL] [Abstract][Full Text] [Related]
18. A novel three-dimensional stromal-based model for in vitro chemotherapy sensitivity testing of leukemia cells.
Aljitawi OS; Li D; Xiao Y; Zhang D; Ramachandran K; Stehno-Bittel L; Van Veldhuizen P; Lin TL; Kambhampati S; Garimella R
Leuk Lymphoma; 2014 Feb; 55(2):378-91. PubMed ID: 23566162
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.
Yamamoto S; Yamauchi T; Kawai Y; Takemura H; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Int J Hematol; 2007 Feb; 85(2):108-15. PubMed ID: 17321987
[TBL] [Abstract][Full Text] [Related]
20. Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.
Yamauchi T; Uzui K; Nishi R; Shigemi H; Ueda T
Anticancer Res; 2014 Apr; 34(4):1657-62. PubMed ID: 24692694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
